Guys I saw on the Novartis ANN thread quite a few people referring to how the Type A REM-L meeting request was knocked back. Yet.....I can’t find any reference to that in any ANNs or news?
I know that REM-L was denied in a CRL from the FDA but then MSB said they would request a Type A meeting. And I’ve read a number of posts of people saying words to the effect of “it’s a shame about the Type A. Will msb release the notes or does today’s announcement admit defeat enough?”
and maybe I’m blind but I can find no such references to the Type A being rejected...?
Guys I saw on the Novartis ANN thread quite a few people...
-
- There are more pages in this discussion • 234 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |